Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05346055 · ClinicalTrials.gov registry record · NA

The Feasibility of Engage Therapy With Video Support for Homebound Older Adults

A NA study of Depression, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT05346055 is a NA study of Depression that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 8 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05346055, a NA study of Depression, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depressive symptoms. Eligible participants will be offered the combination of Engage and Prism 2.0, called Engage-Prism. The investigators hypothesize that the intervention (Engage Therapy With Video Support) will be accepted by participants, improve depressive symptom, and be feasible to complete.

Conditions Studied

Interventions

  • BEHAVIORAL Engage Prism (2.0)

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2022-05-12
Est. Completion 2022-09-30
Phase NA

What the Registry Record Tells You About NCT05346055

The ClinicalTrials.gov registry entry for NCT05346055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (99% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Engage Prism (2.0) is the first listed.

NCT05346055 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05346055 about?

NCT05346055 is a clinical study titled "The Feasibility of Engage Therapy With Video Support for Homebound Older Adults". The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depress...

What is the current status of trial NCT05346055?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-05-12. Estimated completion is 2022-09-30.

What conditions does trial NCT05346055 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT05346055?

The interventions under investigation include: Engage Prism (2.0) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05346055?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05346055 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.